Outcome of Board Meeting dated November 3, 2026

November 3, 2026 Listing Department Code: 531 335 BSE LIMITED P. J. Towers, Dalal Street, Mumbai–400 001 Listing Department Code: ZYDUSWELL NATIONAL STOCK EXCHANGE OF INDIA LIMITED Exchange Plaza, C/1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai–400 051 Sub: Outcome of Board Meeting Ref.: Unaudited financial results for the quarter and half year ended on September 30, 2026, pursuant to regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“the Listing Regulations”) Dear Sir / Madam, The Board of Directors at their meeting held today i.e. November 3, 2026, based on the recommendations of the Audit Committee, approved the unaudited financial results for the quarter and half year ended on September 30, 2026. In this regard, please find enclosed the following: 1. the unaudited financial results (standalone and consolidated) for the quarter and half year ended on September 30, 2026, reviewed by the Audit Committee and taken on record by the Board of Directors, today i.e. November 3, 2026 pursuant to regulation 33 of the Listing Regulations. 2. the Limited Review Reports of Mukesh M. Shah & Co., Chartered Accountants and the Statutory Auditors of the Company certifying the limited review of the unaudited financial results (standalone and consolidated) of the Company for the quarter ended and half year ended on September 30, 2026 pursuant to regulation 33 of the Listing Regulations. The Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed until Thursday, November 5, 2026, and shall re-open for trading on and from Friday, November 6, 2026 for all the Directors and Designated Persons of the Company. The Board meeting commenced at 11:00 a.m. and concluded at 12:20 p.m. Please find the same in order. Thanking you, Yours faithfully, For, ZYDUS WELLNESS LIMITED NANDISH P. JOSHI COMPANY SECRETARY & COMPLIANCE OFFICER Encl.: As above MUKESH MoS HAH & COo CHARTERED ACCOUNTANTS INDEPENDENT AUDITOR'S REVIEW REPORT ON REVIEW OF INTERIM STANDALONE FINANCIAL RESULTS The Board of Directors Zydus Wellness Limited Ahmedabad 1. We have reviewed the accompanying statement of Standalone Unaudited Financial Results of Zydus Wellness Limited ['the Company'], for the quarter and half year ended on September 30, 2026 ['the Statement'] attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended ("the Listing Regulations"). 2. This statement, which is the responsibility of the Company's Management and approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34, 'Interim Financial Reporting' ('Ind AS 34'), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the statement based on our review. 3. We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Institute of Chartered Accountants of India (ICAI). A review of interim financial information consists of making inquiries, primarily of the Company's personnel responsible for financial and accounting matters and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under Section 143(10) of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. For Mukesh M. Shah & Co Chartered Accountants Firm Regn. No. 106625W Place: Ahmedabad Date: November 3, 2026 +91-79-2647 2000 I contact@mmsco.in I www.mmsco.in 7th Floor, Heritage Chambers, Behind Bikanerwala Sweets, Near Azad Society, Nehru Nagar, Ahmedabad-380015 Zydus Wellness Limited wellness Registered office : Zydus corporate Park, scheme No. 63, Survey No. 536 Khoraj (Gandhinagar), Near Vaishnodevi Orcle, ~, .•• ._. ... ,, ...... ',.. Sarkhej-Gandhinagar Highway, Ahmedabad 382 481. Tel. No. (+91-79) 4804 0000 Website: www.zyduswellness.com, CIN: L15201Gl199'1PLC023490 Statement of Standalone Unaudited Financial Results for the Quarter and Half year ended September 30, 2026 , in Million Ouarter Ended Half Year Ended Year Ended September June September September September March Sr. No. Particulars 30, 2026 30, 2026 30, 2025 30, 2026 30, 2025 31, 2026 [Unaudited] [Unaudited] [Unaudited] [Unaudited] [Unaudited] [Audited] 1 Income a Revenue from operations i Sales 1,525 1,353 1,451 2,878 2,754 5,284 ii Other operatirg income 143 177 109 320 215 537 Total Revenue from operations 1,668 1,530 1,560 3,198 2,969 5,821 b Other income 52 49 20 101 27 119 Total Income 1,720 1,579 1,580 3,299 2,996 5,940 2 Expenses a cost of matertals consumed 1,166 1,021 851 2,187 1,691 3,583 b Purchases of Stock-in-Trade 36 24 60 C Olanges in inventories of finished goods, work-in-progress and stock-in-trade (11) 3 61 (8) 33 59 d Employee benefits expense 126 153 134 279 308 568 e Finance costs 34 30 25 64 48 110 f Depreciation and amortisation expense 63 63 64 126 124 250 g Other expenses 185 211 245 396 514 825 h Net gain on foreign currency transactions (5) (12' (5) (13) (55) Total Expenses 1594 1 505 1 368 3 099 2 705 5 340 3 Profit before exceptional items and tax [1-2] 126 74 212 200 291 600 4 Exceptional items [Refer Note 4] 97 97 112 5 Profit before tax [3-4] 126 74 115 200 194 488 6 Tax expense - a Current tax (2) 2 51 59 40 b Deferred tax 12 17 r121 29 13 72 Total tax expense 10 19 39 29 72 112 7 Net Profit [5·6] 116 55 76 171 122 376 8 Other Comprehensive Income [OCI] a Items that will net be reclassified to profit or loss Re-measurement loss on post employment defined benefit plan (1) (3) (1) (5) (4) Income tax effect on above items - I - 1 1 Total Other Comprehensive Income [net of tax] 111 r2 (11 14) (3 9 Total Comprehensive Income [7 +8] 115 55 74 170 118 373 Paid-up equity share capital [Face Value ~ 2/· each] 636 636 636 636 636 636 Reserve exclucing Revaluation Reserve [i.e. Other equity] 39,690 Earnings per share [not annualised for the quarter] a Basic[~] 0.36 0.17 0.24 0.54 0.38 1.18 b Diluted m 0.36 0.17 0.24 0.54 0.38 1.18 Notes: 1. The above financial results were reviewed by the Aucit Committee and then approved by the Board of Directors at their meeting held on November 3, 2026. 2. The above financial results have been prepared in accordance with the COmpanies [Indian Accounting Standards] Rules, 2015 [Ind AS] as amended, prescribed under Section 133 of the Companies Act, 2013, read with relevant rules issued thereunder and in terms of Regulation 33 of Securtties and Exchange Board of India [Listing Obligations and Disclosure Requirements] Regulations, 2015, as amended. 3. The Company operates in one segment, namely "Consumer Products". 4. Exceptional items comprise: Sr. Particulars , in Million No. Quarter Ended Half Year Ended Year Ended September June September September September March 30, 2026 3 [Showing first 8,000 characters — download PDF for full document]